◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

MustGrow Biologics Corp.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Total Revenue 398,018 4.7M 6,479 12,869
Operating Revenue 398,018 4.7M 6,479 12,869
Cost Of Revenue 97,263 0.00 -- --
Gross Profit 300,755 4.7M -- --
Selling General And Administration 3.8M 3.7M 4.5M 2.1M
General And Administrative Expense 3.3M 3.1M 3.8M 1.5M
Research And Development 773,858 857,065 475,858 458,382
Other Operating Expenses 821,842 978,743 731,002 486,907
Operating Expense 5.4M 5.5M 5.7M 3.0M
Operating Income -5.1M -804,988 -5.7M -3.0M
EBIT -5.1M -804,988 -5.6M -3.0M
Interest Expense -- 0.00 10,066 52,765
Interest Expense Non Operating -- 0.00 10,066 52,765
Interest Income 202,404 211,598 103,547 3,322
Interest Income Non Operating 202,404 211,598 103,547 3,322
Net Interest Income 202,404 211,598 93,481 -49,443
Other Income Expense 23,046 -83,550 25,801 -1,932
Special Income Charges -- -- -- 0.00
Gain On Sale Of Security 23,046 -83,550 25,801 -1,932
Pretax Income -4.9M -676,940 -5.6M -3.1M
Tax Effect Of Unusual Items 0.00 0.00 0.00 0.00
Net Income From Continuing And Discontinued Operation -4.9M -676,940 -5.6M -3.1M
Net Income From Continuing Operation Net Minority Interest -4.9M -676,940 -5.6M -3.1M
Net Income Including Noncontrolling Interests -4.9M -676,940 -5.6M -3.1M
Net Income Common Stockholders -4.9M -676,940 -5.6M -3.1M
Net Income -4.9M -676,940 -5.6M -3.1M
EBITDA -5.1M -804,988 -5.6M -3.0M
Normalized EBITDA -5.1M -721,438 -5.6M -3.0M
Basic EPS -0.09 -0.01 -0.11 -0.07
Diluted EPS -0.09 -0.01 -0.11 -0.07
Basic Average Shares 51.6M 49.9M 49.0M 43.7M
Diluted Average Shares 51.6M 49.9M 49.0M 43.7M
Total Unusual Items 23,046 -83,550 25,801 -1,932
Total Unusual Items Excluding Goodwill 23,046 -83,550 25,801 -1,932
Tax Rate For Calcs 0.00 0.00 0.00 0.00
Normalized Income -4.9M -593,390 -5.6M -3.1M
Diluted NI Availto Com Stockholders -4.9M -676,940 -5.6M -3.1M
Net Income Continuous Operations -4.9M -676,940 -5.6M -3.1M
Net Non Operating Interest Income Expense 202,404 211,598 93,481 -49,443
Other Gand A 1.9M 1.8M 2.1M 1.2M
Reconciled Cost Of Revenue 97,263 0.00 -- --
Salaries And Wages 1.5M 1.4M 1.7M 270,810
Selling And Marketing Expense 470,252 558,602 696,820 567,929
Total Expenses 5.5M 5.5M 5.7M 3.0M
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Cash And Cash Equivalents 3.0M 6.8M 7.0M 9.6M
Cash Cash Equivalents And Short Term Investments 3.0M 6.8M 7.0M 9.6M
Receivables 102,776 94,810 87,788 64,296
Inventory 1.4M 0.00 -- --
Prepaid Assets 129,885 25,884 30,411 17,683
Current Assets 4.7M 6.9M 7.1M 9.7M
Gross PPE 180,264 0.00 -- --
Net PPE 180,264 0.00 -- --
Goodwill And Other Intangible Assets 575,575 0.00 -- --
Total Non Current Assets 755,839 0.00 0.00 0.00
Total Assets 5.4M 6.9M 7.1M 9.7M
Current Debt 393,459 618,406 404,276 366,997
Current Debt And Capital Lease Obligation 393,459 618,406 404,276 366,997
Payables And Accrued Expenses 2.5M 321,753 222,302 496,085
Current Deferred Revenue 0.00 272,500 913,700 0.00
Current Liabilities 2.9M 1.2M 1.5M 863,082
Long Term Debt 124,532 140,928 355,058 382,271
Long Term Debt And Capital Lease Obligation 124,532 140,928 355,058 382,271
Total Non Current Liabilities Net Minority Interest 350,107 140,928 355,058 382,271
Total Liabilities Net Minority Interest 3.2M 1.4M 1.9M 1.2M
Common Stock 25.3M 25.1M 24.0M 23.0M
Capital Stock 25.3M 25.1M 24.0M 23.0M
Additional Paid In Capital 5.0M 3.8M 3.8M 2.5M
Retained Earnings -28.2M -23.3M -22.6M -17.0M
Common Stock Equity 2.2M 5.6M 5.2M 8.5M
Stockholders Equity 2.2M 5.6M 5.2M 8.5M
Total Equity Gross Minority Interest 2.2M 5.6M 5.2M 8.5M
Total Capitalization 2.3M 5.7M 5.6M 8.8M
Net Tangible Assets 1.6M 5.6M 5.2M 8.5M
Tangible Book Value 1.6M 5.6M 5.2M 8.5M
Working Capital 1.8M 5.7M 5.6M 8.8M
Invested Capital 2.7M 6.3M 6.0M 9.2M
Total Debt 517,991 759,334 759,334 749,268
Share Issued 51.6M 51.5M 49.7M 47.8M
Ordinary Shares Number 51.6M 51.5M 49.7M 47.8M
Current Deferred Liabilities 0.00 272,500 913,700 0.00
Current Notes Payable -- -- -- 0.00
Finished Goods 1.2M 0.00 -- --
Other Current Borrowings 393,459 618,406 404,276 366,997
Other Properties 180,264 -- -- --
Raw Materials 233,337 0.00 -- --
Taxes Receivable 102,776 94,810 87,788 64,296
Tradeand Other Payables Non Current 225,575 0.00 -- --
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Operating Cash Flow -3.6M -294,764 -3.3M -2.4M
Cash Flow From Continuing Operating Activities -3.6M -294,764 -3.3M -2.4M
Stock Based Compensation 1.5M 926,420 1.7M 270,810
Change In Working Capital 108,911 96,956 603,697 328,521
Change In Receivables -7,966 -7,022 -23,492 -31,025
Change In Inventory -298,180 0.00 -- --
Change In Payables And Accrued Expense 519,058 99,451 -273,783 351,247
Change In Other Working Capital -- -641,200 913,700 --
Other Non Cash Items -272,500 -641,200 10,066 52,765
Repayment Of Debt -241,343 0.00 -- --
Net Issuance Payments Of Debt -241,343 0.00 -- --
Issuance Of Capital Stock -- -- 0.00 6.6M
Net Common Stock Issuance -- -- 0.00 6.6M
Financing Cash Flow -241,343 95,750 653,750 8.7M
Cash Flow From Continuing Financing Activities -241,343 95,750 653,750 8.7M
Changes In Cash -3.8M -199,014 -2.6M 6.3M
Beginning Cash Position 6.8M 7.0M 9.6M 3.3M
End Cash Position 3.0M 6.8M 7.0M 9.6M
Free Cash Flow -3.6M -294,764 -3.3M -2.4M
Change In Prepaid Assets -104,001 4,527 -12,728 8,299
Common Stock Issuance -- -- 0.00 6.6M
Long Term Debt Payments -241,343 0.00 -- --
Net Income From Continuing Operations -4.9M -676,940 -5.6M -3.1M
Net Long Term Debt Issuance -241,343 0.00 -- --
Proceeds From Stock Option Exercised 0.00 95,750 653,750 2.1M
NEWS
Loading news...
TRENDING
Loading...